Arkolith/Insider Trading/IGMS/Form 4

Decker Lisa Lynn

CHIEF BUSINESS OFFICERIGM Biosciences, Inc. (IGMS) · full profile →Form 4 · filed Jul 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 19, 2024Grant(A)17K——77K
Jul 19, 2024Grant(A)3K——80K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 19, 2024Disposed to issuer(D)60K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-020001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML